A detailed history of Occidental Asset Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Occidental Asset Management, LLC holds 695 shares of VRTX stock, worth $313,424. This represents 0.05% of its overall portfolio holdings.

Number of Shares
695
Previous 458 51.75%
Holding current value
$313,424
Previous $214,000 50.93%
% of portfolio
0.05%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$460.0 - $505.78 $109,020 - $119,869
237 Added 51.75%
695 $323,000
Q2 2024

Jul 15, 2024

BUY
$392.81 - $485.53 $179,906 - $222,372
458 New
458 $214,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Occidental Asset Management, LLC Portfolio

Follow Occidental Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occidental Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Occidental Asset Management, LLC with notifications on news.